Various studies have been conducted on the surveillance, treatment, and prognosis of colon cancer in elderly patients, including the use of serum carcino-embryonic antigen measurement, computed tomography, and biomarkers like CDX2. Adjuvant treatments such as bevacizumab plus oxaliplatin-based chemotherapy have also been studied for their effectiveness in colon cancer patients.